ClinicalTrials.gg
RecruitingNCT03677843Updated Apr 19, 2024

Multidimensional Approach in Patients With Severe Cerebral Palsy, Prospective Cohort(MAPCP Cohort)-Offline

An observational study in Cerebral Palsy, Spastic, sponsored by Ju Seok Ryu. Recruiting at 1 site in Korea, Republic of. Open to participants aged 2 Years to 10 Years. Per ClinicalTrials.gov, last updated 2024-04-19.

Sponsored by Ju Seok Ryu · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Oct 2018; still recruiting 8 years later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
2 Years to 10 Years
Sex
All
01

Study summary

In children with cerebral palsy, secondary problems lead to hip dislocation and scoliosis. But There is no definite evidence for the dislocation of hip and scoliosis. The investigators want to verify evidence of scoliosis and dislocation of hip.

Read the detailed description

Observation cohort study. The investigators will measure for finding evidence by checking the x-ray photograph, hip adductor muscles pressure test and electromyography(EMG test) test of hip adductor and spine muscles

02

Conditions studied

  • Cerebral Palsy, Spastic

Keywords

  • hip dislocation
  • GMFCS level 3,4,5
  • scoliosis
03

In context

Cerebral Palsy

1,936 studies on the registry are indexed under Cerebral Palsy; 458 are open to participants now.

This study's planned enrollment of 100 is above the median of 63 across 472 observational studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Ju Seok Ryu is the lead sponsor of 5 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Serious cerebral palsy children(GMFCS 3,4,5) have secondary problems such as hip dislocation and scoliosis. and There are many preliminary reports that hip dislocation occurs from 2 years of age or older.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Severe cerebral palsy patients(GMFCS level 3,4,5)
  • 2 to 10 years old

Exclusion criteria

Exclusion Criteria:

  • Those who disagree with the study.
  • other than cerebral palsy.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • cerebral palsy

    They are included in GMFCS level 3, 4, 5. and they have diplegia or quadriplegia

06

What researchers measure

Primary outcomes

  1. hip adductor and spin muscles electromyography(EMG) test

    Use EMG to check the activity of the hip adductor and spine muscles of participants. This figures will give investigators a look at the association with a hip dislocation.

    Time frame: once at study, when patient enrolled

Secondary outcomes

  1. Whole spine AP and total Hip AP X-ray photograph

    Whole spine and total Hip joint are checked with X-ray photograph. and investigators will check the progress of hip dislocation and spinal scoliosis.

    Time frame: once at study, when patient enrolled and after once every six months for three years

  2. hip adductor muscles pressure meter test

    Pressures of hip adductors muscles are measured from pressure meter. and This figures will give investigators a look at the association with a hip dislocation.

    Time frame: once at study, when patient enrolled

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2018 (actual). Primary completion is estimated for Dec 2024, 74 months after the start.

Of 214 non-industry observational studies under Cerebral Palsy, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 60. This study's planned 74 months is above that.

Counting every sponsor, half of 218 studies reached it within 21 months; a quarter within 8 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 10, 2018
First posted
Sep 19, 2018
StartActual
Oct 16, 2018
Primary completionEst.
Dec 31, 2024
CompletionEst.
Dec 31, 2024
Last update
Apr 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03677843
Lead sponsor
Ju Seok Ryu
Responsible party
Ju Seok Ryu (Associate Professor, Seoul National University Hospital) — Sponsor-investigator
First posted
Sep 19, 2018
Start date
Oct 16, 2018
Primary completion
Dec 31, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Apr 19, 2024

Study contacts

JuSuk Ryu, M.D, PhD
Contact
01040@snubh.org
+82-31-787-7739
YulHyeon Park, M.D
Contact
82246@snubh.org
+82-31-787-4999

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion